Cancer Treatment Reviews
Volume 35, Issue 7 , Pages 553-562, November 2009

Survivin: A new target for anti-cancer therapy

  • Bríd M. Ryan

      Affiliations

    • Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4258, USA
    • Laboratory of Human Carcinogenesis, Centre for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4258, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 301 496 5886; fax: +1 301 496 1497.
    • ,
  • Norma O’Donovan

      Affiliations

    • National Institute for Cellular Biotechnology, Dublin City University, Dublin 9, Ireland
    • Tel.: +353 1 700 7497; fax: +353 1 700 5484.
    • ,
  • Michael J. Duffy

      Affiliations

    • Department of Pathology and Laboratory Medicine, St. Vincent’s University Hospital, Dublin 4, Ireland
    • UCD School of Medicine and Medical Science, Conway Institute, University College Dublin, Dublin 4, Ireland
    • Tel.: +353 1 209 4378; fax: +353 1 269 6018.

Received 3 February 2009; received in revised form 13 May 2009; accepted 15 May 2009. published online 26 June 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(09)00085-1

doi:10.1016/j.ctrv.2009.05.003

Cancer Treatment Reviews
Volume 35, Issue 7 , Pages 553-562, November 2009

Article Tools

* Image Usage & Resolution